Knight Therapeutics Stock
Price
Target price
?
?
2.610%
0.15
2.610%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Knight Therapeutics in the next few years
Pros
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Knight Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Knight Therapeutics | 2.610% | 2.609% | -4.839% | 46.040% | 58.602% | 80.982% | 70.520% |
| MicroPlanet Technology Corp | -4.880% | -0.637% | 20.930% | 22.835% | 2.632% | -12.360% | 6.122% |
| Biomark Diagnostics Inc. | 1.270% | 0.000% | 0.000% | 35.897% | 15.217% | 165.000% | 109.211% |
| Avricore Health Inc. | 0.000% | 14.000% | -17.391% | -30.488% | 23.913% | -74.554% | -70.619% |
News
Cannae Q2 Earnings Call Highlights
Key Points
- Interested in Cannae Holdings, Inc.? Here are five stocks we like better.
- Cannae strengthened liquidity by selling its 49% stake in The Watkins Company for $90 million and
Knight Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Knight Therapeutics Inc.? Here are five stocks we like better.
- Record first-half performance: Knight Therapeutics reported CAD 293 million in revenue, CAD 52 million
Review of 31 Studies Finds Vegan Dog Food and Vegan Cat Food Are Well Digested
LONDON, UK /ACCESS Newswire / July 30, 2026 / A new scientific review has found that nutritionally sound vegan dog food, vegan cat food and vegetarian pet diets are generally well digested
